Joint Formulary & PAD

House dust mites allergen extract - Allergic rhinitis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative
Formulations :
  • Not Specified
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
House dust mites allergen extract
Indication :
Allergic rhinitis
Group Name :
Keywords :
allergic disorders, dust mite allergy, allergens, allergen therapy, hyposensitising agents,
Brand Names Include :
Acarizax
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that House dust mites allergen extract is used to treat.

Committee Recommendations (1)

This drug / device has not yet been assessed for formulary status and is not currently on the APC work-plan.

This drug / device has not yet been evaluated by the Surrey Heartlands Area Prescribing Committee (APC). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined. It is recommended that clinicians contact their medicines management team for further information and advice before prescribing this drug / device.
The APC will consider recommending prescribing of this treatment upon submission of a formal request with its associated evidence. Clinicans can contact syheartlandsccg.APC@nhs.net
if they wish to make a submission.